Skip to content

Buprenorphine Maintenance Protocol - 1

Buprenorphine Maintenance Protocol

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000205
Enrollment
0
Registered
1999-09-21
Start date
1990-10-31
Completion date
1993-09-30
Last updated
2016-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders

Brief summary

The purpose of this study is to compare the efficacy of buprenorphine versus methadone.

Interventions

DRUGBuprenorphine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of California, Los Angeles
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.

Exclusion criteria

Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and /or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe

Design outcomes

Primary

MeasureTime frame
Retention
Opiate use
Opiate craving
Adverse events

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026